Naltrexone Is Alternative Treatment for Opioid Addiction, Penn-Led Study Finds

Original post: Newswise - Drug and Drug Abuse Naltrexone Is Alternative Treatment for Opioid Addiction, Penn-Led Study Finds

The once-a-month drug naltrexone was more effective at preventing drug relapse in ex-prisoners addicted to heroin and other opioids compared to the usual treatment modalities, including counseling and community treatment programs, according to results from a multisite, randomized trial led by researchers at the Center for Studies of Addiction at the Perelman School of Medicine at the University of Pennsylvania and published online today in the New England Journal of Medicine.

That First Drink Is a Learning Experience

Original post: Newswise - Drug and Drug Abuse That First Drink Is a Learning Experience

In a recent study published in The Journal of Neuroscience, a research team led by Dr. Dorit Ron at the University of California, San Francisco examined whether a single exposure to alcohol can induce memory and behavioral changes that could promote future drinking.

TSRI Scientists Create Vaccine Against Dangerous Designer Opioids

Original post: Newswise - Drug and Drug Abuse TSRI Scientists Create Vaccine Against Dangerous Designer Opioids

Newswise imageWith use of synthetic opioid “designer drugs” rising, scientists from The Scripps Research Institute have a new strategy to curb addiction and even prevent fatal overdoses, reporting successful preclinical tests of a vaccine that prevents the synthetic opioid fentanyl from reaching the brain.

Restricting Ketamine Would Have ‘Dire Consequences’ for Surgery in Low-Resource Countries, Anesthesiologists Warn

Proposals to restrict access to ketamine by making it a “Schedule I” drug would have a major impact on the availability of anesthesia and surgery in low- to middle-income countries (LMICs)–where ketamine is often the only general anesthetic drug available, according to a series of commentaries in Anesthesia & Analgesia.